WebApr 14, 2024 · Revolution Medicines Stock Performance. NASDAQ:RVMD opened at $22.17 on Wednesday. The stock has a 50-day simple moving average of $23.28 and a 200-day simple moving average of $22.73. WebGet the latest Revolution Medicines Inc (RVMD) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …
What is the Market
WebMar 1, 2024 · In a report released on February 27, Jonathan Chang from SVB Securities maintained a Buy rating on Revolution Medicines ( RVMD – Research Report ), with a price target of $30.00. The company’s... WebMar 29, 2024 · In 2024, RVMD's revenue was $35.38 million, an increase of 20.38% compared to the previous year's $29.39 million. Losses were -$248.71 million, 32.9% more than in 2024. According to 16 analysts, the average rating for RVMD stock is "Buy." The 12-month stock price forecast is $32.51, which is an increase of 50.58% from the latest price. british intelligence agencies mi6
The Salem News
WebApr 8, 2024 · Volatility Over Time: RVMD's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of US stocks. About the Company Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. WebApr 8, 2024 · Revolution Medicines (NASDAQ:RVMD) has a market capitalization of $1.88 billion and generates $35.38 million in revenue each year. The company earns $ … WebApr 12, 2024 · RVMD closed up 0.29 percent on Thursday, April 6, 2024, on 51 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected. 1 Watcher Watchlist Portfolio Trend Table & Recent EOD Trading Signals Historical RVMD trend table... british intelligence